Timothy F. Murphy, MD, senior associate dean for clinical and translational research and SUNY Distinguished Professor of medicine, is leading a major initiative addressing health disparities among people living on Buffalo’s East Side.
Results of a study by lead author Kelseanna Hollis-Hansen, PhD, a former graduate research assistant in the Department of Pediatrics, point to the need for expanding mobile and farmers markets to improve the diets of people who live in low-income communities.
Fifteen students in the MD-PhD program at the Jacobs School of Medicine and Biomedical Sciences presented posters at the Tri-Institutional MD-PhD Research Day last fall at the Jacobs School building in downtown Buffalo.
A UB spinoff company that is developing a low-cost blood test to screen high-risk patients for unruptured brain aneurysms has received $750,000 Phase II Small Business Innovation Research (SBIR) funding from the National Science Foundation (NSF).
Jerrold C. Winter, PhD, professor of pharmacology and toxicology, is the author of an entertaining and informative new book, “Our Love Affair with Drugs: The History, the Science, the Politics,” published by Oxford University Press.
Otolaryngology surgeons and residents, facial plastic surgeons and other health care personnel got to experience cutting edge technology and techniques during Rhinofest 2019, which took place this fall at the Jacobs School of Medicine and Biomedical Sciences building.
Eight faculty members from the Jacobs School of Medicine and Biomedical Sciences were among those honored for notable achievement and service at the 16th annual University at Buffalo Celebration of Faculty and Staff Academic Excellence.
They spent their middle school and high school years with a firsthand view of the development of the burgeoning Buffalo Niagara Medical Campus, including the sparkling new downtown building that houses the Jacobs School of Medicine and Biomedical Sciences.
Garwood Medical Devices, LLC, has been granted “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the company’s BioPrax device, a tool it is developing to help eliminate biofilm infections on prosthetic knee implants.
Twenty-five faculty members with a variety of clinical and research experience — representing eight medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.